论文部分内容阅读
目的:研究养血清脑颗粒联合贝那普利治疗原发性高血压的效果。方法:选取83例原发性高血压患者,随机对照组41例和观察组42例。对照组患者采用贝那普利治疗,观察组患者采用养血清脑颗粒联合贝那普利治疗。观察两组患者头痛缓解率、不良反应发生率及治疗前后血压改善情况。结果:观察组头痛缓解率为95.24%,明显高于对照组的75.61%,差异有统计学意义(P<0.05)。治疗后两组患者血压水平均较治疗前有改善,组间治疗前后比较差异有统计学意义(P<0.05);治疗后观察组血压水平较治疗组改善更明显,组间比较差异有统计学意义(P<0.05)。观察组患者不良反应发生率为4.88%,对照组为4.76%,差异无统计学意义(P>0.05)。结论:养血清脑颗粒联合贝那普利治疗原发性高血压效果确切,可以有效改善患者血压水平,提升患者生活质量,值得临床推广应用。
Objective: To study the effect of Yangxue Qingnao granule combined with benazepril on essential hypertension. Methods: 83 patients with essential hypertension were selected, 41 cases were randomized and 42 cases were observed. Patients in the control group were treated with benazepril, while those in the observation group were treated with nourishing qingnao granules combined with benazepril. The relief rate of headache, the incidence of adverse reactions and the improvement of blood pressure before and after treatment in both groups were observed. Results: The relief rate of headache in observation group was 95.24%, which was significantly higher than that in control group (75.61%), the difference was statistically significant (P <0.05). After treatment, the blood pressure of both groups improved compared with that before treatment, and there was significant difference between the two groups before and after treatment (P <0.05); after treatment, the blood pressure of the observation group improved more obviously than the treatment group, Significance (P <0.05). The incidence of adverse reactions in the observation group was 4.88% and in the control group was 4.76%, the difference was not statistically significant (P> 0.05). Conclusion: Yangxue Qingnao Granules combined with benazepril is effective in treating essential hypertension, which can effectively improve the blood pressure level and improve the quality of life of patients, which is worthy of clinical application.